GARY W. PACE - 10 Nov 2023 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ Gary Pace
Issuer symbol
CRDF
Transactions as of
10 Nov 2023
Net transactions value
+$22,491
Form type
4
Filing time
14 Nov 2023, 16:24:42 UTC
Previous filing
20 Jun 2023
Next filing
19 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRDF Common Stock Purchase $22,491 +22,950 +3.6% $0.9800 667,761 10 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.95 to $1.01. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.